ClinicalTrials.gov record
Completed Phase 1 Interventional

Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer

ClinicalTrials.gov ID: NCT03122496

Public ClinicalTrials.gov record NCT03122496. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study of Durvalumab (MEDI4736) With Tremelimumab in Combination With Image Guided Stereotactic Body Radiotherapy (SBRT) in the Treatment of Metastatic Anaplastic Thyroid Cancer

Study identification

NCT ID
NCT03122496
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Enrollment
13 participants

Conditions and interventions

Interventions

  • Stereotactic Body Radiotherapy (SBRT) Radiation
  • durvalumab Drug
  • tremelimumab Drug

Radiation · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 24, 2017
Primary completion
Jun 2, 2022
Completion
Jun 2, 2022
Last update posted
Jun 7, 2022

2017 – 2022

United States locations

U.S. sites
8
U.S. states
2
U.S. cities
8
Facility City State ZIP Site status
Memoral Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920
Memoral Sloan Kettering Monmouth Middletown New Jersey 07748
Memorial Sloan Kettering Bergen Montvale New Jersey 07645
Memorial Sloan Kettering Commack Commack New York 11725
Memoral Sloan Kettering Westchester Harrison New York 10604
Memorial Sloan Kettering Cancer Center New York New York 10065
Memorial Sloan Kettering @ Rockville Rockville Centre New York 11570
Memorial Sloan Kettering Nassau Uniondale New York 11553

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03122496, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 7, 2022 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03122496 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →